In Vivo Quantification of Short Chain Fatty Acids Production in the Human Colon
NCT ID: NCT02378376
Last Updated: 2015-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2013-07-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of the Bioavailability of Short Chain Fatty Acids in Healthy Humans
NCT01757379
Effect of Different Bran-based Dietary Platforms on the Colon Metabolism in Healthy Volunteers
NCT02422537
Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS)
NCT02693782
Increasing Ferulic Acid Bioavailability in Bran
NCT00777543
The Effect of Prebiotics on Gastrointestinal Functioning and Metabolism
NCT02491125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wheat derived fiber fraction 1
Arabinoxylan oligosaccharides
Arabinoxylan oligosaccharides
Wheat derived fiber fraction 2
Dietary fiber enriched bran
Dietary fiber enriched bran
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arabinoxylan oligosaccharides
Dietary fiber enriched bran
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18.5 and 27 kg/m2
Exclusion Criteria
* Antibiotics in the month prior to the study
* Former surgeries on the gastrointestinal tract, with the exception of an appendectomy
* use of the following types of medications with effects on the gastrointestinal tract during the last 2 weeks prior to the study (spasmolytica, anti-diarrhea, anti-constipation, probiotics)
* Chronic disease of the gastrointestinal tract such as Crohn's disease, ulcerative colitis, irritable bowel syndrome, chronic constipation, chronic frequent diarrhea, clinically relevant lactose intolerance
* Pregnancy, pregnancy desire or breastfeeding
* Diabetes (type 1 and 2)
* Blood donation in the past 3 months prior to the study
* Abnormal hemoglobin (Hb) levels in blood, men must have a Hb level between 14.0 and 18.0 g / dL and women between 12.0 and 16.0 g / dL
* Participation in studies in the past year in which radiation was used.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristin Verbeke
Professor Kristin Verbeke
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
s55383
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.